Trials / Unknown
UnknownNCT04304612
A Cost Effective and Time Saving Blood Test to Detect Six Human Bloodborne Infectious Diseases
A Cost Effective and Time Saving Blood Test to Detect Six Human Bloodborne Infectious Diseases (SAFE-Blood)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- University Hospital, Montpellier · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The consortium will develop a new in vitro diagnostic (IVD) test to screen donated blood for bloodborne infectious pathogens, saving blood banks time and costs required for analysis of mandatory pathogens. The IVD test is a multiplex immunoassay that simultaneously screens for six bloodborne infectious diseases per blood sample. In this project, a mix of diagnostic protein markers will be developed and validated to lowdown an IVD test ready for commercial scale-up and CE-IVD certification.
Conditions
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2023-12-01
- Completion
- 2023-12-30
- First posted
- 2020-03-11
- Last updated
- 2021-09-14
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04304612. Inclusion in this directory is not an endorsement.